Issue 11, 2022

A 2,7-dichlorofluorescein derivative to monitor microcalcifications

Abstract

Herein, we report the crystal structure of 2,7-dichlorofluorescein methyl ester (DCF-ME) and its fluorescence response to hydroxyapatite binding. The reported fluorophore is very selective for staining the bone matrix and provides turn-on fluorescence upon hydroxyapatite binding. The reported fluorophore can readily pass the cell membrane of the C2C12 cell line, and it is non-toxic for the cell line. The reported fluorophore DCF-ME may find applications in monitoring bone remodeling and microcalcification as an early diagnosis tool for breast cancer and age-related macular degeneration.

Graphical abstract: A 2,7-dichlorofluorescein derivative to monitor microcalcifications

Supplementary files

Article information

Article type
Communication
Submitted
01 Sep 2022
Accepted
04 Oct 2022
First published
10 Oct 2022
This article is Open Access
Creative Commons BY license

Mol. Syst. Des. Eng., 2022,7, 1415-1421

A 2,7-dichlorofluorescein derivative to monitor microcalcifications

P. Tholen, C. N. Brown, C. Keil, A. Bayir, H. Zeng, H. Haase, R. B. Thompson, I. Lengyel and G. Yücesan, Mol. Syst. Des. Eng., 2022, 7, 1415 DOI: 10.1039/D2ME00185C

This article is licensed under a Creative Commons Attribution 3.0 Unported Licence. You can use material from this article in other publications without requesting further permissions from the RSC, provided that the correct acknowledgement is given.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements